New book by Larry Connors Click here Improve your trading - See how
This test, formerly referred to as WheatRite, is being marketed in Canada as the ReadRite alpha-amylase test for use with Tyrian's Reader. The test provides grain industry stakeholders with a rapid, easy to use, and quantitative method for determining the quality of wheat at Point of Need.
"The results of the evaluation and the launch of the ReadRite product is a major accomplishment for Tyrian, and validates our DiagnostIQ(TM) platform in the agriculture industry," said Jenny Harry, PhD, Chief Executive Officer of Tyrian Diagnostics. "We have developed a strong working relationship with Bayer CropScience, and we look forward to continued collaboration on this and future products."
Tyrian will continue to manufacture ReadRite(R) test kits in house, whilst concurrently establishing outsourced manufacturing of the kits to meet forecast sales increases in North America and other regions.
About ReadRite alpha-amylase test
The ReadRite(R) alpha-amylase test is a rapid wheat quality test that can be completed in five minutes and enables growers to make an on-farm assessment of the extent of rain damage to a crop in order to separate sound grain from damaged grain. The test is available as a rapid visual test that can be interpreted without instrumentation, or used in conjunction with the ReadRite(R) Reader to provide a more definitive quantitative result. Rain damage has a significant impact on the pricing of harvested wheat. Grading must be conducted by trading authorities prior to sale and/or export, but also may be performed at multiple points in the chain, from on-farm to wheat processor, to monitor and confirm grain quality.
About Tyrian's DiagnostIQ Reader
Tyrian's DiagnostIQ Reader is a proprietary device that utilizes optical detection technology combined with customized software to provide a quantitative measure of the level of diagnostic targets in samples processed in Tyrian's point of need DiagnostIQ tests. The Reader can be configured to detect diagnostic targets in a wide range of sample types, and therefore has utility in the healthcare, agricultural, and veterinary fields.
About Tyrian Diagnostics
Tyrian Diagnostics (ASX:TDX) is a diagnostics company with expertise in biomarker discovery and validation and diagnostic test development with a core focus on respiratory and infectious diseases. Tyrian's product pipeline includes:
-- ReadRite(R) tests for crop quality management, which are partnered with Bayer CropScience; and
-- a rapid test for active tuberculosis, in collaboration with the US-based group Becton, Dickinson and Company.
In addition, Tyrian has many partnering opportunities in alternative fields, given its capabilities to work across the entire spectrum of diagnostic test development - from identification and isolation of biomarkers, point-of-need test design, clinical development or field testing to final product. Core technology of the company includes the DiagnostIQ test format, a handheld device that allows rapid and easy detection of protein markers associated with particular medical, veterinary or agricultural conditions.
Additional information about Tyrian Diagnostics can be found at www.tyriandx.com
SOURCE: Tyrian Diagnostics Limited
Tyrian Diagnostics Dr. Jenny Harry, +61 2 8877 8947 Chief Executive Officer or Blueprint Life Science Group AU Investor Relations: Sabrina Antoniou, +61 2 9519 5537 Mobile: +61 400 788 277 U.S. Investor Relations: Remy Bernarda, 1-415-375-3340 ext. 2022 Mobile: 1-415-203-6386
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.
It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.
HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.
The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302
© Copyright 2009 The Connors Group, Inc.
